Diagnostics for Infectious Disease: Utility of AI in Lab Management, Testing, Clinical Decision Support, and Analysis
Improving Clinical Outcomes through Novel Technologies
8/25/2026 - August 26, 2026 ALL TIMES EDT
At the 18th annual Diagnostics for Infectious Disease conference, industry leaders will explore how AI can enhance lab management, streamline testing workflows, support clinical decision-making, and improve data analysis across hospitals, labs, and public health settings. Participants will examine AI-enabled tools for optimizing laboratory operations, accelerating pathogen detection, and enhancing multiplex testing. Sessions will also highlight the use of predictive analytics for outbreak surveillance, variant detection, and clinical guidance. The program brings together laboratorians, clinicians, diagnostics developers, and policymakers to collaboratively address opportunities to leverage AI to improve the speed, accuracy, and impact of testing while navigating the complexities of modern clinical and public-health laboratories.
Preliminary Agenda

BRINGING INFECTIOUS DISEASE TESTING CLOSER TO PATIENTS

The Transformation of Rural Health and the Role of Diagnostics

Photo of Ken Bahk, PhD, CEO, Lakewood Holdings , CEO , HEI Partners
Ken Bahk, PhD, CEO, Lakewood Holdings , CEO , HEI Partners

The Transformation of Rural Health and the Role of Diagnostics Rural healthcare systems face unique challenges—from limited specialist access to higher disease burdens. With new federal momentum through the $50 billion Rural Health Transformation Program, the landscape is shifting. This session explores how advances in AI-enabled lab management, point-of-care testing, and clinical decision support are reshaping diagnostics in underserved communities—improving early detection, informing clinical decisions, and driving more equitable outcomes across rural America.

Evaluating HPV and STI Self-Collection: Laboratory Insights and the Evolution toward Home-Based Screening

Photo of Meghan W. Starolis, MS, PhD, HCLD(ABB), Senior Science Director, Infectious Disease, Quest Diagnostics , Senior Science Director , Infectious Disease , Quest Diagnostics Nichols Institute
Meghan W. Starolis, MS, PhD, HCLD(ABB), Senior Science Director, Infectious Disease, Quest Diagnostics , Senior Science Director , Infectious Disease , Quest Diagnostics Nichols Institute

This session will explore how self-collected specimens are transforming sexual health testing and screening for cervical cancer. The talk reviews laboratory validation and regulatory requirements, workflow considerations, and performance of self-collection for HPV and other STIs. It highlights evidence supporting accuracy, patient acceptability, and expanded access, while discussing operational challenges and quality assurance as collection shifts from clinic-based toward scalable, reliable home-based screening models.

Access, Accuracy, and Speed: Rethinking Infectious Disease Testing for Decentralized Care

Photo of Shaunak Roy, PhD, Senior Vice President, Research and Development, Visby Medical , Senior Vice President R&D , Research and Development , Visby Medical
Shaunak Roy, PhD, Senior Vice President, Research and Development, Visby Medical , Senior Vice President R&D , Research and Development , Visby Medical

EMERGING TECHNOLOGIES AND AI IN INFECTIOUS DISEASE TESTING

Impact of a Deep Learning Sepsis Prediction Model on Quality of Care and Survival

Photo of Gabriel Wardi, MD, MPH, FACEP, Associate Professor, Chief, Division of Critical Care Department of Emergency Medicine Division of Pulmonary Critical Care and Sleep Medicine, UC San Diego , Associate Professor, Chief , Division of Critical Care Department of Emergency Medicine Division of Pulmonary Critical Care and Sleep Medicine , UC San Diego
Gabriel Wardi, MD, MPH, FACEP, Associate Professor, Chief, Division of Critical Care Department of Emergency Medicine Division of Pulmonary Critical Care and Sleep Medicine, UC San Diego , Associate Professor, Chief , Division of Critical Care Department of Emergency Medicine Division of Pulmonary Critical Care and Sleep Medicine , UC San Diego

In this presentation, the speaker will examine how emerging artificial intelligence technologies are redefining sepsis identification, refining risk stratification, and supporting clinical decision-making across acute and critical care settings. The session will focus on real-world applications of machine learning and large language models, emphasizing how these tools can complement clinician expertise, promote earlier intervention, and advance quality improvement efforts in high-acuity environments.

CRISPR-Cas12a Assay for Tuberculosis Detection

Zhen Huang, PhD, Assistant Professor, John W. Deming Department of Medicine, Center for Cellular and Molecular Diagnostics, Tulane University School of Medicine , Assistant Professor , John W. Deming Department of Medicine, Center for Cellular and Molecular Diagnostics , Tulane University School of Medicine

From Code to Bench: Practical Applications of AI-Guided Scripting for Infectious Disease Diagnostics

Photo of Lucas J. Osborn, PhD, D(ABMM), Director of Microbiology, Keck Medical Center of USC; Assistant Professor, Clinical Pathology, Keck School of Medicine, USC , Director of Microbiology , Keck Medical Center of USC
Lucas J. Osborn, PhD, D(ABMM), Director of Microbiology, Keck Medical Center of USC; Assistant Professor, Clinical Pathology, Keck School of Medicine, USC , Director of Microbiology , Keck Medical Center of USC

Panel Moderator:

PANEL DISCUSSION:
Point-Counterpoint Debate: Should AI Be Applied to Infectious Disease Testing?

Photo of Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California , Dir Clinical Microbiology Lab , Pathology & Laboratory Medicine , Childrens Hospital Los Angeles
Jennifer Dien Bard, PhD, D(ABMM), Director, Microbiology and Virology, Children’s Hospital Los Angeles; Professor, Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California , Dir Clinical Microbiology Lab , Pathology & Laboratory Medicine , Childrens Hospital Los Angeles

OPPORTUNITIES AND CHALLENGES IN RAPID ASTs

NGS Approaches to Rapid ASTs

Photo of Patricia Simner, PhD, D(ABMM), Associate Professor, Pathology, Director, Bacteriology, Division of Medical Microbiology, Johns Hopkins University School of Medicine , Assoc Prof , Pathology , Johns Hopkins Univ
Patricia Simner, PhD, D(ABMM), Associate Professor, Pathology, Director, Bacteriology, Division of Medical Microbiology, Johns Hopkins University School of Medicine , Assoc Prof , Pathology , Johns Hopkins Univ

Panel Moderator:

PANEL DISCUSSION:
Emerging Opportunities and Challenges in Rapid ASTs

Photo of Nathan Ledeboer, PhD, Professor and Vice Chair, Pathology; Medical Director, Medical College of Wisconsin , Prof & Vice Chair , Pathology & Lab Medicine , Medical College of Wisconsin
Nathan Ledeboer, PhD, Professor and Vice Chair, Pathology; Medical Director, Medical College of Wisconsin , Prof & Vice Chair , Pathology & Lab Medicine , Medical College of Wisconsin

PLENARY SESSION

Panel Moderator:

PLENARY FIRESIDE CHAT:
Regulatory Outlook for Diagnostics

Brian P. Carey, Partner, Hogan Lovells US LLP , Partner , Hogan Lovells US LLP

Panelists:

Photo of Jai Pandey, PhD, Head, Global Device Regulatory IVD/CDx and Digital Health, Sanofi , Global Device Regulatory Head for IVD and Digital Health , Global Device Regulatory for IVD/CDx and Digital Health , Sanofi
Jai Pandey, PhD, Head, Global Device Regulatory IVD/CDx and Digital Health, Sanofi , Global Device Regulatory Head for IVD and Digital Health , Global Device Regulatory for IVD/CDx and Digital Health , Sanofi
Photo of Zach Rothstein, PhD, Executive Director, AdvaMedDx , Executive Director, AdvaMedDx , Technology & Regulatory Affairs , AdvaMedDx
Zach Rothstein, PhD, Executive Director, AdvaMedDx , Executive Director, AdvaMedDx , Technology & Regulatory Affairs , AdvaMedDx
Photo of Sheila D. Walcoff, Founding Principal & CEO, Goldbug Strategies LLC , Founding Principal & CEO , Goldbug Strategies LLC
Sheila D. Walcoff, Founding Principal & CEO, Goldbug Strategies LLC , Founding Principal & CEO , Goldbug Strategies LLC

For more details on the conference, please contact:

Iris Goldman

Conference Producer

Cambridge Healthtech Institute

Email: igoldman@healthtech.com

 

For sponsorship information, please contact:

Jon Stroup

Lead Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-5483

Email: jons@healthtech.com